ATA909477A - METHOD FOR PRODUCING NEW 3.20-DIOXO-7 ALPHA-HALOGEN-4-PREGNENES AND -1,4-PREGNADIENES - Google Patents

METHOD FOR PRODUCING NEW 3.20-DIOXO-7 ALPHA-HALOGEN-4-PREGNENES AND -1,4-PREGNADIENES

Info

Publication number
ATA909477A
ATA909477A AT0909477A AT909477A ATA909477A AT A909477 A ATA909477 A AT A909477A AT 0909477 A AT0909477 A AT 0909477A AT 909477 A AT909477 A AT 909477A AT A909477 A ATA909477 A AT A909477A
Authority
AT
Austria
Prior art keywords
pregnadienes
pregnenes
dioxo
alpha
halogen
Prior art date
Application number
AT0909477A
Other languages
German (de)
Other versions
AT373269B (en
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/753,257 external-priority patent/US4076708A/en
Application filed by Scherico Ltd filed Critical Scherico Ltd
Priority to AT245582A priority Critical patent/AT377267B/en
Publication of ATA909477A publication Critical patent/ATA909477A/en
Application granted granted Critical
Publication of AT373269B publication Critical patent/AT373269B/en

Links

Classifications

    • E—FIXED CONSTRUCTIONS
    • E04—BUILDING
    • E04G—SCAFFOLDING; FORMS; SHUTTERING; BUILDING IMPLEMENTS OR AIDS, OR THEIR USE; HANDLING BUILDING MATERIALS ON THE SITE; REPAIRING, BREAKING-UP OR OTHER WORK ON EXISTING BUILDINGS
    • E04G11/00—Forms, shutterings, or falsework for making walls, floors, ceilings, or roofs
    • E04G11/06—Forms, shutterings, or falsework for making walls, floors, ceilings, or roofs for walls, e.g. curved end panels for wall shutterings; filler elements for wall shutterings; shutterings for vertical ducts
    • E04G11/20—Movable forms; Movable forms for moulding cylindrical, conical or hyperbolical structures; Templates serving as forms for positioning blocks or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0084—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkylene group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • E—FIXED CONSTRUCTIONS
    • E04—BUILDING
    • E04G—SCAFFOLDING; FORMS; SHUTTERING; BUILDING IMPLEMENTS OR AIDS, OR THEIR USE; HANDLING BUILDING MATERIALS ON THE SITE; REPAIRING, BREAKING-UP OR OTHER WORK ON EXISTING BUILDINGS
    • E04G17/00—Connecting or other auxiliary members for forms, falsework structures, or shutterings
    • E04G17/14—Bracing or strutting arrangements for formwalls; Devices for aligning forms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Architecture (AREA)
  • Engineering & Computer Science (AREA)
  • Civil Engineering (AREA)
  • Mechanical Engineering (AREA)
  • Structural Engineering (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
AT0909477A 1976-12-22 1977-12-19 METHOD FOR PRODUCING NEW 3.20-DIOXO-7 ALPHA-HALOGEN-4-PREGNENES AND -1,4-PREGNADIENES AT373269B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT245582A AT377267B (en) 1976-12-22 1982-06-24 METHOD FOR PRODUCING NEW 3.20-DIOXO7ALPHA-HALOGEN-4-PREGNENEN AND -1,4-PREGNADIENEN

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75325676A 1976-12-22 1976-12-22
US05/753,257 US4076708A (en) 1976-12-22 1976-12-22 Process for the preparation of 7α-halogeno-3-oxo-4-dehydro steroids and novel 7α-halogeno derivatives produced thereby

Publications (2)

Publication Number Publication Date
ATA909477A true ATA909477A (en) 1983-05-15
AT373269B AT373269B (en) 1984-01-10

Family

ID=27115720

Family Applications (2)

Application Number Title Priority Date Filing Date
AT0909477A AT373269B (en) 1976-12-22 1977-12-19 METHOD FOR PRODUCING NEW 3.20-DIOXO-7 ALPHA-HALOGEN-4-PREGNENES AND -1,4-PREGNADIENES
AT0575980A AT377566B (en) 1976-12-22 1980-11-25 DEVICE FOR TENSIONING SHEET PARTS

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT0575980A AT377566B (en) 1976-12-22 1980-11-25 DEVICE FOR TENSIONING SHEET PARTS

Country Status (20)

Country Link
JP (1) JPS604198B2 (en)
AR (1) AR226806A1 (en)
AT (2) AT373269B (en)
BE (1) BE862089A (en)
DE (1) DE2756550C2 (en)
DK (1) DK153494C (en)
FI (1) FI63947C (en)
FR (1) FR2384793A1 (en)
GB (1) GB1575983A (en)
HK (1) HK584A (en)
HU (1) HU179784B (en)
IE (1) IE45950B1 (en)
IL (1) IL53636A (en)
MY (1) MY8500082A (en)
NL (1) NL180479C (en)
NO (1) NO151826C (en)
NZ (1) NZ186031A (en)
PT (1) PT67432B (en)
SE (1) SE429865B (en)
SG (1) SG58683G (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109680036A (en) 2017-10-02 2019-04-26 爱科来株式会社 The measurement of glycated proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3429926A (en) * 1964-05-25 1969-02-25 Squibb & Sons Inc 7-halo and 6-halo,6-dehydro a-norprogesterones

Also Published As

Publication number Publication date
PT67432B (en) 1979-05-23
SE429865B (en) 1983-10-03
BE862089A (en) 1978-06-20
IL53636A0 (en) 1978-03-10
FI63947C (en) 1983-09-12
DE2756550A1 (en) 1978-07-06
JPS604198B2 (en) 1985-02-01
HK584A (en) 1984-01-13
AR226806A1 (en) 1982-08-31
NL7714056A (en) 1978-06-26
FR2384793A1 (en) 1978-10-20
NO774359L (en) 1978-06-23
MY8500082A (en) 1985-12-31
AT373269B (en) 1984-01-10
GB1575983A (en) 1980-10-01
IL53636A (en) 1983-05-15
HU179784B (en) 1982-12-28
NZ186031A (en) 1984-07-31
SE7714538L (en) 1978-06-23
SG58683G (en) 1985-01-11
NL180479C (en) 1987-03-02
NO151826C (en) 1985-06-12
FR2384793B1 (en) 1981-11-13
NO151826B (en) 1985-03-04
IE45950B1 (en) 1983-01-12
IE45950L (en) 1978-06-22
DK569977A (en) 1978-09-28
NL180479B (en) 1986-10-01
DK153494B (en) 1988-07-18
FI773825A (en) 1978-06-23
AT377566B (en) 1985-04-10
ATA575980A (en) 1982-04-15
PT67432A (en) 1978-01-01
FI63947B (en) 1983-05-31
JPS5379850A (en) 1978-07-14
DE2756550C2 (en) 1986-10-16
DK153494C (en) 1989-02-20

Similar Documents

Publication Publication Date Title
AT366374B (en) METHOD FOR PRODUCING NEW N3-SUBSTITUTED 5,5-DIMETHYLHYDANTOINES
AT360663B (en) METHOD FOR PRODUCING NEW 6,7- BENZOMORPHANS
AT367401B (en) METHOD FOR PRODUCING NEW 6-HYDROXYALKYL-1,4-DIHYDROPYRIDINE COMPOUNDS
AT356671B (en) METHOD FOR PRODUCING NEW N, N'-THIO- -DI-CARBAMATES
AT364359B (en) METHOD FOR PRODUCING NEW AMINOALKYLIDENAMINO-1,4-DIHYDROPYRIDINES
AT354626B (en) METHOD FOR PRODUCING NEW 7-ACYL-AMINO-8-OXO-3-OXA-1-AZABICYCLO / 4.2.0 / OCTAN-2-CARBONIC ACID DERIVATIVES
AT350043B (en) METHOD FOR PRODUCING NEW 3-POLYHALOGENETHYL-2, 2-DIMETHYLCYCLOPROPANE-CARBONIC ACIDS
AT354434B (en) METHOD FOR PRODUCING NEW 1,4-DIPHENYL-3-PYRAZOLIN-5-ONES
AT355305B (en) METHOD FOR PRODUCING NEW ETHERED, ELECTROLYTE-FREE METHYLOLAMINOTRIAZINES
AT356126B (en) METHOD FOR PRODUCING 3,4-DIHYDRO-2-METHYL-4-OXO-2H-1,2-BENZOTHIAZINE-3-CARBOXAMIDE- -1,1-DIOXIDE
ATA151379A (en) METHOD FOR PRODUCING NEW 9ALPHA, 21-DIHALOGEN-11BETA, 17ALPHA-DIHYDROXY-6ALPHA-FLUOR -16BETA-METHYL-PREGNA-1,4-DIEN COMPOUNDS
AT372681B (en) METHOD FOR PRODUCING NEW 1,5-DISUBSTITUTED HYDANTOINES
AT379593B (en) METHOD FOR PRODUCING NEW TRANS-2,3DIHYDRO-7-METHOXY-3-METHYL-2-SUBST. PHENYLBENZOFURAN DERIVATIVES
AT350071B (en) METHOD FOR PRODUCING THE NEW 3,5,5-TRIMETHYLHEXANOYL FERROCENS
AT343624B (en) METHOD FOR PRODUCING NEW N-ALKYL -2,4-DINITRO-6- TRIFLUORMETHYLDIPHENYLAMINES
AT356815B (en) METHOD FOR PRODUCING 3 ', 4'-DIDEOXY-KANAMYCIN B
AT373269B (en) METHOD FOR PRODUCING NEW 3.20-DIOXO-7 ALPHA-HALOGEN-4-PREGNENES AND -1,4-PREGNADIENES
ATA569677A (en) METHOD FOR PRODUCING NEW SUBSTITUTED 2,3-ALKYLENE-BIS (OXY) BEZAMIDEN
AT377267B (en) METHOD FOR PRODUCING NEW 3.20-DIOXO7ALPHA-HALOGEN-4-PREGNENEN AND -1,4-PREGNADIENEN
AT353797B (en) METHOD FOR PRODUCING THE NEW N-2,6-DICHLORPHENYL-2-AMINO-PYRIMIDINE
AT356125B (en) METHOD FOR PRODUCING NEW 1-ARYLOXY -2,3-EPOXYPROPANES
ATA272280A (en) METHOD FOR PRODUCING NEW 1,4DIHYDROPYRIDINE COMPOUNDS
AT347920B (en) METHOD FOR PRODUCING THE NEW 2,5-DICHLOR-4-BROMPHENYLAZO-4-CHLORPHENYL SULFID
AT361940B (en) METHOD FOR PRODUCING NEW N, N'-THIO- BIS-OXIMCARBAMATES
ATA491379A (en) METHOD FOR PRODUCING NEW 2.9 ALPHA

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee